Course: “Fixed-Duration vs. Continuous Therapy in Hematology: Patterns and Recurrences in Treatment Timing Strategies”

A course dedicated to the evolution of therapeutic strategies in hematology, comparing fixed-duration treatments with ongoing therapies.
The program covers acute leukemias, chronic lymphocytic leukemia, lymphomas, and multiple myeloma, with an in-depth look at immunotherapy, molecularly targeted drugs, transplantation, CAR-T therapy, bispecific antibodies, and molecular classification.
The event will take place on November 6 and 7, 2026, at the DoubleTree by Hilton in Brescia. Participation is free upon online registration, and ECM accreditation is available through two tracks, each worth 8 credits.